Vincent K - Search Results

1

Leveraging rAAV bioprocess understanding and next generation bioanalytics development.

Escandell JM, Pais DA, Carvalho SB, Vincent K, Gomes-Alves P, Alves PM. Escandell JM, et al. Among authors: vincent k. Curr Opin Biotechnol. 2022 Apr;74:271-277. doi: 10.1016/j.copbio.2021.12.009. Epub 2022 Jan 7. Curr Opin Biotechnol. 2022. PMID: 35007989 Free article. Review.

2

Characteristics of Minimally Oversized Adeno-Associated Virus Vectors Encoding Human Factor VIII Generated Using Producer Cell Lines and Triple Transfection.

Nambiar B, Cornell Sookdeo C, Berthelette P, Jackson R, Piraino S, Burnham B, Nass S, Souza D, O'Riordan CR, Vincent KA, Cheng SH, Armentano D, Kyostio-Moore S. Nambiar B, et al. Hum Gene Ther Methods. 2017 Feb;28(1):23-38. doi: 10.1089/hgtb.2016.124. Hum Gene Ther Methods. 2017. PMID: 28166648 Free PMC article.

3

Generation and characterization of adeno-associated virus producer cell lines for research and preclinical vector production.

Martin J, Frederick A, Luo Y, Jackson R, Joubert M, Sol B, Poulin F, Pastor E, Armentano D, Wadsworth S, Vincent K. Martin J, et al. Among authors: vincent k. Hum Gene Ther Methods. 2013 Aug;24(4):253-69. doi: 10.1089/hgtb.2013.046. Epub 2013 Aug 9. Hum Gene Ther Methods. 2013. PMID: 23848282

4

Scaleable chromatographic purification process for recombinant adeno-associated virus (rAAV).

O'Riordan CR, Lachapelle AL, Vincent KA, Wadsworth SC. O'Riordan CR, et al. Among authors: vincent ka. J Gene Med. 2000 Nov-Dec;2(6):444-54. doi: 10.1002/1521-2254(200011/12)2:6<444::AID-JGM132>3.0.CO;2-1. J Gene Med. 2000. PMID: 11199265

5

AAVS1-Targeted Plasmid Integration in AAV Producer Cell Lines.

Luo Y, Frederick A, Martin JM, Scaria A, Cheng SH, Armentano D, Wadsworth SC, Vincent KA. Luo Y, et al. Hum Gene Ther Methods. 2017 Jun;28(3):124-138. doi: 10.1089/hgtb.2016.158. Epub 2017 Apr 14. Hum Gene Ther Methods. 2017. PMID: 28504553

6

Analysis of recombinant adeno-associated virus packaging and requirements for rep and cap gene products.

Vincent KA, Piraino ST, Wadsworth SC. Vincent KA, et al. J Virol. 1997 Mar;71(3):1897-905. doi: 10.1128/JVI.71.3.1897-1905.1997. J Virol. 1997. PMID: 9032320 Free PMC article.

7

Catheter-mediated delivery of adenoviral vectors expressing beta-adrenergic receptor kinase C-terminus inhibits intimal hyperplasia and luminal stenosis in rabbit iliac arteries.

Luo Z, Palasis M, Yamakawa M, Liu LX, Vincent KA, Trudell L, Akita GA, Koch WJ, Cheng SH, Gregory RJ, Jiang C. Luo Z, et al. J Gene Med. 2004 Oct;6(10):1061-8. doi: 10.1002/jgm.592. J Gene Med. 2004. PMID: 15386742

8

A hypoxic inducible factor-1 alpha hybrid enhances collateral development and reduces vascular leakage in diabetic rats.

Kajiwara H, Luo Z, Belanger AJ, Urabe A, Vincent KA, Akita GY, Cheng SH, Mochizuki S, Gregory RJ, Jiang C. Kajiwara H, et al. J Gene Med. 2009 May;11(5):390-400. doi: 10.1002/jgm.1318. J Gene Med. 2009. PMID: 19291676

9

Gene therapy progress and prospects: therapeutic angiogenesis for ischemic cardiovascular disease.

Vincent KA, Jiang C, Boltje I, Kelly RA. Vincent KA, et al. Gene Ther. 2007 May;14(10):781-9. doi: 10.1038/sj.gt.3302953. Gene Ther. 2007. PMID: 17476300 Review.

10

Enhancement of Fas ligand-induced inhibition of neointimal formation in rabbit femoral and iliac arteries by coexpression of p35.

Luo Z, Garron T, Palasis M, Lu H, Belanger AJ, Scaria A, Vincent KA, Date T, Akita GY, Cheng SH, Barry J, Gregory RJ, Jiang C. Luo Z, et al. Among authors: vincent ka. Hum Gene Ther. 2001 Dec 10;12(18):2191-202. doi: 10.1089/10430340152710531. Hum Gene Ther. 2001. PMID: 11779403

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

677 results

Search Page